Mepolizumab assoc'd w/ clinical benefits in EGPA, including in patients w/ and w/o a vasculitic phenotype. Abs 1074 #ACR22 @RheumNow https://t.co/VCGhGaci8b https://t.co/OV8A1vsx1G
Links:
Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polya…
http://ow.ly/Msl550LyLmA
13-11-2022
